Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CYRN Stock Summary
In the News
Why Is Cyren (CYRN) Stock Down 9% Today?
Cyren (NASDAQ: CYRN ) stock is falling on Monday as the cybersecurity company's shares continue to experience volatility. Investors keeping track of CYRN stock will note that it's been on a wild ride these last few days.
Why Is Cyren (CYRN) Stock Down 27% Today?
Cyren (NASDAQ: CYRN ) stock is dropping on Thursday as the cybersecurity company deals with recent headwinds. That includes the company facing delisting from the Nasdaq Exchange.
Why Is Cyren (CYRN) Stock Up 43% Today?
Cyren (NASDAQ: CYRN ) stock is rising after signing a letter of intent for the sale of some assets to Opin Kerfi. According to a press release, Cyren is planning to sell Iceland-based assets connected to its anti-malware business.
Cyren Ltd (CYRN) Q3 2022 Earnings Call Transcript
Cyren Ltd (NASDAQ:CYRN ) Q3 2022 Results Conference Call November 14, 2022 4:30 PM ET Company Participants Brian Dunn - General Counsel Brett Jackson - CEO and Director Jason Parikh - Finance Consultant Operator Greetings, and welcome to Cyren's Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
7 Under-the-Radar Cybersecurity Stocks With 500% Upside Potential
The trend of major companies undergoing impactful hacking attacks definitely isn't going away. In just the last several weeks, a breach at Uber (NYSE: UBER ) exposed the personal information of the company's data, while a cyberattack of JPMorgan (NYSE: JPM ) reportedly ” blocked the bank's network infrastructure” and a hack of “more than a dozen U.S. airports' websites” made it impossible to access areas of their sites for a while.
These Are The 10 Best-Performing Packaged Software Companies In 2022
The packaged software industry includes companies that offer multiple software programs bundled together to make a complete set.
Cyren Ltd (CYRN) CEO Brett Jackson on Q2 2022 Results - Earnings Call Transcript
Cyren Ltd (NASDAQ:CYRN ) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Brett Jackson - CEO & Director Brian Dunn - General Counsel Jason Parikh - Finance Consultant Conference Call Participants Operator Greetings, and welcome to Cyren's Second Quarter 2022 Earnings Call. [Operator Instructions].
Cyren Schedules Second Quarter 2022 Earnings Release for Monday, August 15, 2022
MCLEAN, VA / ACCESSWIRE / August 1, 2022 / Cyren (NASDAQ:CYRN) today announced it will release its second quarter financial results on Monday, August 15, 2022, after U.S. markets close. The company will also host a conference call at 4:30 p.m.
3 Penny Stocks to Watch as the Market Dips Today
Check these penny stocks out for your watchlist The post 3 Penny Stocks to Watch as the Market Dips Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Penny Stocks Today: Why IMPP, CYRN and EFOI Are Soaring Wednesday
Penny stocks are a hot topic for traders today and we're diving into the top ones that investors will want to keep an eye on for Wednesday! The post Top Penny Stocks Today: Why IMPP, CYRN and EFOI Are Soaring Wednesday appeared first on InvestorPlace.
CYRN Financial details
CYRN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.05 | 13.39 | 13.92 | 12.06 | 7.98 | |
Net income per share | -7.65 | -7.24 | -6.53 | -5.72 | -5.9 | |
Operating cash flow per share | -3.53 | -4.27 | -2.49 | -2.79 | -4.1 | |
Free cash flow per share | -6.13 | -6.25 | -4.37 | -3.86 | -4.3 | |
Cash per share | 11.72 | 6.55 | 4.19 | 3.08 | 1.1 | |
Book value per share | 23.02 | 11.88 | 8.96 | 3.99 | 3.54 | |
Tangible book value per share | 7.31 | 0.95 | -1.63 | -5.71 | -2.78 | |
Share holders equity per share | 23.02 | 11.88 | 8.96 | 3.99 | 3.54 | |
Interest debt per share | 1.02 | 3.82 | 7.14 | 10.86 | 5.16 | |
Market cap | 5.12M | 8.05M | 3.53M | 3.11M | 1.14M | |
Enterprise value | -18.87M | 474.1K | 11.1M | 24.91M | 15.66M | |
P/E ratio | -0.33 | -0.41 | -0.2 | -0.18 | -0.05 | |
Price to sales ratio | 0.17 | 0.22 | 0.09 | 0.09 | 0.04 | |
POCF ratio | -0.71 | -0.7 | -0.51 | -0.37 | -0.07 | |
PFCF ratio | -0.41 | -0.48 | -0.29 | -0.27 | -0.07 | |
P/B Ratio | 0.11 | 0.25 | 0.14 | 0.26 | 0.08 | |
PTB ratio | 0.11 | 0.25 | 0.14 | 0.26 | 0.08 | |
EV to sales | -0.61 | 0.01 | 0.29 | 0.68 | 0.5 | |
Enterprise value over EBITDA | 2.2 | -0.04 | -1.04 | -2.96 | -0.94 | |
EV to operating cash flow | 2.62 | -0.04 | -1.61 | -2.96 | -0.98 | |
EV to free cash flow | 1.5 | -0.03 | -0.92 | -2.14 | -0.93 | |
Earnings yield | -3.06 | -2.41 | -5.1 | -5.56 | -20.18 | |
Free cash flow yield | -2.45 | -2.08 | -3.41 | -3.75 | -14.71 | |
Debt to equity | 0 | 0.31 | 0.77 | 2.58 | 1.36 | |
Debt to assets | 0 | 0.17 | 0.31 | 0.53 | 0.41 | |
Net debt to EBITDA | 2.8 | 0.57 | -0.71 | -2.59 | -0.87 | |
Current ratio | 2.03 | 1.5 | 1.04 | 0.48 | 0.58 | |
Interest coverage | -6.6 | -75.69 | -31.27 | -9.56 | -16.03 | |
Income quality | 0.46 | 0.59 | 0.38 | 0.49 | 0.7 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.23 | 0.28 | 0.26 | 0.3 | |
Research and developement to revenue | 0.32 | 0.45 | 0.41 | 0.44 | 0.57 | |
Intangibles to total assets | 0.5 | 0.49 | 0.48 | 0.5 | 0.53 | |
Capex to operating cash flow | 0.74 | 0.46 | 0.75 | 0.39 | 0.05 | |
Capex to revenue | -0.17 | -0.15 | -0.13 | -0.09 | -0.02 | |
Capex to depreciation | -1.06 | -0.88 | -0.73 | -0.44 | -0.15 | |
Stock based compensation to revenue | 0.07 | 0.04 | 0.06 | 0.07 | 0.08 | |
Graham number | 62.94 | 43.99 | 36.29 | 22.67 | 21.66 | |
ROIC | -0.29 | -0.46 | -0.33 | -0.28 | -0.51 | |
Return on tangible assets | -0.49 | -0.63 | -0.57 | -0.58 | -1.07 | |
Graham Net | 4.41 | -2.93 | -8.31 | -12.23 | -7.01 | |
Working capital | 14.32M | 7.66M | 595K | -12.93M | -5.38M | |
Tangible asset value | 14.96M | 2.54M | -4.5M | -17.24M | -10.85M | |
Net current asset value | 11.08M | -5.27M | -20.61M | -34.89M | -24.98M | |
Invested capital | 0 | 0.31 | 0.77 | 2.58 | 1.36 | |
Average receivables | 2.98M | 3.27M | 2.92M | 1.57M | 879.5K | |
Average payables | 890.5K | 1.34M | 1.43M | 991.5K | 937K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 34.25 | 37.19 | 20.79 | 9.63 | 9.35 | |
Days payables outstanding | 31.2 | 41.87 | 27.78 | 19.72 | 25.68 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 10.66 | 9.81 | 17.55 | 37.9 | 39.03 | |
Payables turnover | 11.7 | 8.72 | 13.14 | 18.51 | 14.21 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.33 | -0.61 | -0.73 | -1.43 | -1.67 | |
Capex per share | -2.61 | -1.98 | -1.87 | -1.08 | -0.2 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.91 | 1.63 | 1.45 | 0.74 | 1.2 | |
Net income per share | -1.48 | -1.66 | -1.3 | -0.75 | -1.31 | |
Operating cash flow per share | -1.25 | -0.79 | 0.48 | -1.04 | -0.71 | |
Free cash flow per share | -1.15 | -0.79 | 0.48 | -1.07 | -0.71 | |
Cash per share | 4.6 | 0.95 | 3.53 | 1.14 | 2.89 | |
Book value per share | 5.33 | 4.25 | 3.79 | 0.8 | 0.81 | |
Tangible book value per share | -1.22 | -1.21 | -0.96 | -0.34 | -0.96 | |
Share holders equity per share | 5.33 | 4.25 | 3.79 | 0.8 | 0.81 | |
Interest debt per share | 5.24 | 2.27 | 3.7 | 1.89 | 3.09 | |
Market cap | 2.44M | 1.32M | 25.2M | 15.62M | 4.58M | |
Enterprise value | 4.93M | 7.26M | 25.84M | 21.24M | 5.15M | |
P/E ratio | -0.11 | -0.04 | -0.97 | -0.68 | -0.19 | |
Price to sales ratio | 0.33 | 0.18 | 3.47 | 2.72 | 0.82 | |
POCF ratio | -0.5 | -0.37 | 10.5 | -1.93 | -1.39 | |
PFCF ratio | -0.54 | -0.37 | 10.53 | -1.9 | -1.39 | |
P/B Ratio | 0.12 | 0.07 | 1.33 | 2.52 | 1.21 | |
PTB ratio | 0.12 | 0.07 | 1.33 | 2.52 | 1.21 | |
EV to sales | 0.66 | 0.99 | 3.56 | 3.69 | 0.92 | |
Enterprise value over EBITDA | -0.91 | -1.17 | -4.91 | -4.03 | -1.04 | |
EV to operating cash flow | -1.01 | -2.04 | 10.76 | -2.63 | -1.56 | |
EV to free cash flow | -1.1 | -2.04 | 10.8 | -2.58 | -1.56 | |
Earnings yield | -2.37 | -5.67 | -0.26 | -0.37 | -1.34 | |
Free cash flow yield | -1.84 | -2.69 | 0.09 | -0.53 | -0.72 | |
Debt to equity | 0.98 | 0.53 | 0.97 | 2.32 | 3.71 | |
Debt to assets | 0.5 | 0.26 | 0.31 | 0.34 | 0.41 | |
Net debt to EBITDA | -0.46 | -0.95 | -0.12 | -1.06 | -0.12 | |
Current ratio | 0.96 | 0.58 | 1.31 | 1.35 | 1.29 | |
Interest coverage | 0 | -323.65 | -29.62 | -28.51 | -17.58 | |
Income quality | 0.84 | 0.48 | -0.37 | 1.33 | 0.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.31 | 0.34 | 0.37 | 0.39 | 0.38 | |
Research and developement to revenue | 0.55 | 0.7 | 0.61 | 0.66 | 0.63 | |
Intangibles to total assets | 0.64 | 0.64 | 0.41 | 0.21 | 0.24 | |
Capex to operating cash flow | -0.08 | 0 | 0 | 0.02 | 0 | |
Capex to revenue | 0.05 | 0 | 0 | -0.03 | 0 | |
Capex to depreciation | 1.07 | 0 | -0.01 | -0.21 | -0.01 | |
Stock based compensation to revenue | 0.1 | 0.09 | 0.09 | 0.08 | 0.1 | |
Graham number | 13.34 | 12.58 | 10.53 | 3.67 | 4.89 | |
ROIC | -0.1 | -0.19 | -0.14 | -0.23 | -0.25 | |
Return on tangible assets | -0.39 | -0.53 | -0.19 | -0.18 | -0.23 | |
Graham Net | 0.33 | -3.25 | -4.13 | -3.29 | -3.53 | |
Working capital | -934K | -5.38M | 5.04M | 6.23M | 4.01M | |
Tangible asset value | -4.74M | -5.47M | -4.77M | -2.64M | -4.47M | |
Net current asset value | 4.84M | -12.27M | -18.01M | -11.75M | -13.03M | |
Invested capital | 0.98 | 0.53 | 0.97 | 2.32 | 3.71 | |
Average receivables | 2.62M | 2.31M | 1.15M | 1.64M | 1.5M | |
Average payables | 1.13M | 989K | 1M | 895K | 1.04M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 46.13 | 9.77 | 18.61 | 27.76 | 19.78 | |
Days payables outstanding | 21.78 | 24.52 | 21.98 | 23.91 | 33.38 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.95 | 9.21 | 4.84 | 3.24 | 4.55 | |
Payables turnover | 4.13 | 3.67 | 4.1 | 3.76 | 2.7 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.28 | -0.39 | -0.34 | -0.93 | -1.61 | |
Capex per share | 0.1 | 0 | 0 | -0.02 | 0 |
CYRN Frequently Asked Questions
What is Cyren Ltd. stock symbol ?
Cyren Ltd. is a IL stock and trading under the symbol CYRN
What is Cyren Ltd. stock quote today ?
Cyren Ltd. stock price is $0.2182 today.
Is Cyren Ltd. stock public?
Yes, Cyren Ltd. is a publicly traded company.